L-lactate dehydrogenase A chain mRNA · NUCLEIC-ACID · Homo sapiens
This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.
Move to another high-traffic target or paste a specific ChEMBL target ID.
Structured disease, protein, and project context should read before the lower-level identity rail.
As of 2026-09-13L-lactate dehydrogenase A chain mRNA shows approved-linked disease relevance led by primary hyperoxaluria. 1 more disease program remain visible in the same review block. 1 linked drug keeps the current disease frame grounded. Protein identity stays anchored to UniProt ENSG00000134333. Start with primary hyperoxaluria, then reuse UniProt ENSG00000134333 as the stable protein anchor across project notes and exports.
Start with primary hyperoxaluria, then reuse UniProt ENSG00000134333 as the stable protein anchor across project notes and exports.
L-lactate dehydrogenase A chain mRNA shows approved-linked disease relevance led by primary hyperoxaluria. 1 more disease program remain visible in the same review block. 1 linked drug remains visible in the same block.
Start review with primary hyperoxaluria because it currently carries approved-linked support. Linked drugs include NEDOSIRAN SODIUM. This disease block keeps the Open Targets-ready contract explicit while current evidence comes from ChEMBL mechanism and indication mappings.
Disease source · ChEMBL drug mechanism + indication proxyL-lactate dehydrogenase A chain mRNA
Review this target as L-lactate dehydrogenase A chain mRNA, mapped to UniProt ENSG00000134333.
Protein source · UniProt accession via ChEMBL component mappingKeep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.
This review treats L-lactate dehydrogenase A chain mRNA as ChEMBL target CHEMBL4627242, mapped to UniProt ENSG00000134333. Disease framing currently uses the Open Targets-ready proxy contract.
Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.
Choose the first block or source based on the question you are trying to answer.
Start here when your first question is whether L-lactate dehydrogenase A chain mRNA is the right protein anchor across sources, using UniProt ENSG00000134333 as the stable mapping.
Jump to Protein ContextUse this block first when you need to confirm why primary hyperoxaluria is currently framed as approved-linked support. It currently carries 1 linked drug in the same disease frame.
Jump to Disease ContextOpen the one-page evidence card when you want the rationale, activity base, and attribution together.
Open Review-ready CardVerify identity, organism, and the fastest next research jumps from the same page.
| Preferred Name | L-lactate dehydrogenase A chain mRNA |
| Target Type | NUCLEIC-ACID |
| Organism | Homo sapiens |
| UniProt | ENSG00000134333 |
Reviewable protein naming and mapping context for this target snapshot.
| Protein Label | L-lactate dehydrogenase A chain mRNA |
| UniProt Accession | ENSG00000134333 |
| Component Type | Rna |
L-lactate dehydrogenase A chain mRNA
Review this target as L-lactate dehydrogenase A chain mRNA, mapped to UniProt ENSG00000134333.
Open Targets-ready disease context using the current target-indication evidence contract.
L-lactate dehydrogenase A chain mRNA shows approved-linked disease relevance led by primary hyperoxaluria. 1 more disease program remain visible in the same review block.
Start review with primary hyperoxaluria because it currently carries approved-linked support. Linked drugs include NEDOSIRAN SODIUM. This disease block keeps the Open Targets-ready contract explicit while current evidence comes from ChEMBL mechanism and indication mappings.